Anti-GLP1R antagonist antibodies (Sciwind Bio)

抗GLP1R抗体(先为达)

Report date: 2026/04/13 20:02:18
NME

Base Information

Drug NameAnti-GLP1R antagonist antibodies (Sciwind Bio)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionGlucagon-like peptide 1 receptor antagonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsHypoglycemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHangzhou Sciwind Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Sciwind Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsHypoglycemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A